{
  "variants": [
    {
      "gene": "LRRK2",
      "protein_change": "Y1699C",
      "variant_string": "LRRK2_Y1699C",
      "functional_evidence": {
        "disease_mechanism": "LRRK2 is a stress-responsive scaffold mediating MAPK pathways. Loss of protection in mutants (Y1699C/G2019S) leads to increased vulnerability to oxidative stress, which is linked to Parkinson's disease.",
        "assay": "Cell viability under oxidative stress (H2O2) in HEK293 and SH-SY5Y cells",
        "results": "Wild-type LRRK2 enhances stress tolerance, while Y1699C and G2019S mutants do not. The protective effect is dependent on the kinase domain and ERK activation.",
        "controls": "Wild-type LRRK2 (control) vs. Y1699C/G2019S mutants (variant controls).",
        "statistical_analysis": "Not explicitly mentioned, but results are described as 'supported by our findings'.",
        "total_controls": "Wild-type (benign) and Y1699C/G2019S (pathogenic) variants used as controls.",
        "strength": "PS3_supporting"
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "G2019S",
      "variant_string": "LRRK2_G2019S",
      "functional_evidence": {
        "disease_mechanism": "LRRK2 is a stress-responsive scaffold mediating MAPK pathways. Loss of protection in mutants (Y1699C/G2019S) leads to increased vulnerability to oxidative stress, which is linked to Parkinson's disease.",
        "assay": "Cell viability under oxidative stress (H2O2) in HEK293 and SH-SY5Y cells",
        "results": "Wild-type LRRK2 enhances stress tolerance, while Y1699C and G2019S mutants do not. The protective effect is dependent on the kinase domain and ERK activation.",
        "controls": "Wild-type LRRK2 (control) vs. Y1699C/G2019S mutants (variant controls).",
        "statistical_analysis": "Not explicitly mentioned, but results are described as 'supported by our findings'.",
        "total_controls": "Wild-type (benign) and Y1699C/G2019S (pathogenic) variants used as controls.",
        "strength": "PS3_supporting"
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "R1441C",
      "variant_string": "LRRK2_R1441C",
      "functional_evidence": {
        "disease_mechanism": "LRRK2 is a stress-responsive scaffold mediating MAPK pathways. Loss of protection in mutants (Y1699C/G2019S) leads to increased vulnerability to oxidative stress, which is linked to Parkinson's disease.",
        "assay": "Cell viability in SHSY5Y cells",
        "results": "R1441C expression results in a loss of basal cell viability, indicating impaired cellular function.",
        "controls": "Wild-type LRRK2 (control) vs. R1441C mutant (variant control).",
        "statistical_analysis": "Not explicitly mentioned, but results are described as 'supported by prior studies' (Greggio et al., 2006; West et al., 2005).",
        "total_controls": "Wild-type (benign) and R1441C (pathogenic) variants used as controls.",
        "strength": "PS3_supporting"
      }
    }
  ],
  "summary": "All three variants (Y1699C, G2019S, R1441C) demonstrate functional evidence of pathogenicity in the context of LRRK2's role in oxidative stress and Parkinson's disease. The strength of evidence is 'PS3_supporting' for each variant, as they show reduced cellular viability or impaired stress tolerance compared to wild-type controls, with variant controls used in the assays."
}